Client News
CENTOGENE Launches PICOPglobal: Two Year Global Study on Colon- and Pancreas-Carcinoma
27th June 2019
Newron Pharmaceuticals now also listed on the primary market of the Düsseldorf Stock Exchange and on XETRA
27th June 2019
Vivoryon Therapeutics AG enters myeloid immune checkpoint drug discovery, and collaborates with the University of Kiel to select cancer therapy candidates from its QPCTL inhibitor portfolio
27th June 2019
NOXXON announces launch of capital increase right issue for an amount of up to Euro 3.9 M
26th June 2019
MagForce AG successfully resolves and completes capital increase from authorized capital under exclusion of statutory subscription rights
25th June 2019
CENTOGENE Four Year Study Reveals Importance of Lyso-Gb1 in Monitoring Gaucher Disease Patients
25th June 2019
Verona Pharma Strengthens its Clinical Team Ahead of Phase 3 Development of Ensifentrine
25th June 2019
Expedeon AG introduces Lightning-Link® Metal Labelling Kits to support single cell analysis
24th June 2019
NOXXON announces leading international pharma to evaluate NOX-A12 in new indication
24th June 2019
There is no more content to load